GB9924958D0 - Treatment of neuropathy - Google Patents

Treatment of neuropathy

Info

Publication number
GB9924958D0
GB9924958D0 GBGB9924958.3A GB9924958A GB9924958D0 GB 9924958 D0 GB9924958 D0 GB 9924958D0 GB 9924958 A GB9924958 A GB 9924958A GB 9924958 D0 GB9924958 D0 GB 9924958D0
Authority
GB
United Kingdom
Prior art keywords
neuropathy
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9924958.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GBGB9924958.3A priority Critical patent/GB9924958D0/en
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of GB9924958D0 publication Critical patent/GB9924958D0/en
Priority to IL13907300A priority patent/IL139073A0/en
Priority to IL152925A priority patent/IL152925A/en
Priority to ES04010436T priority patent/ES2295726T3/en
Priority to DE60037347T priority patent/DE60037347T2/en
Priority to PT04010436T priority patent/PT1440709E/en
Priority to EP00309129A priority patent/EP1129706A3/en
Priority to DK04010436T priority patent/DK1440709T3/en
Priority to EP04010436A priority patent/EP1440709B1/en
Priority to AT04010436T priority patent/ATE380049T1/en
Priority to MYPI20004933 priority patent/MY127989A/en
Priority to MYPI20024290 priority patent/MY138266A/en
Priority to CA002323839A priority patent/CA2323839C/en
Priority to CO00080163A priority patent/CO5271711A1/en
Priority to PE2000001133A priority patent/PE20010754A1/en
Priority to AU66650/00A priority patent/AU781550B2/en
Priority to HU0004120A priority patent/HUP0004120A3/en
Priority to NZ50769000A priority patent/NZ507690A/en
Priority to KR1020000062129A priority patent/KR20010051181A/en
Priority to JP2000322510A priority patent/JP2001122803A/en
Priority to US10/206,615 priority patent/US20030162782A1/en
Priority to JP2002297617A priority patent/JP2003119131A/en
Priority to IL15292502A priority patent/IL152925A0/en
Priority to US10/731,905 priority patent/US20040122010A1/en
Priority to CY20081100193T priority patent/CY1107285T1/en
Ceased legal-status Critical Current

Links

GBGB9924958.3A 1999-10-21 1999-10-21 Treatment of neuropathy Ceased GB9924958D0 (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
GBGB9924958.3A GB9924958D0 (en) 1999-10-21 1999-10-21 Treatment of neuropathy
IL13907300A IL139073A0 (en) 1999-10-21 2000-10-16 Treatment of neuropathy
IL152925A IL152925A (en) 1999-10-21 2000-10-16 Pharmaceutical compositions for treatment of neuropathy comprising an inhibitor of cyclic guanosine 3',5'-monophosphate phosphodiesterase 5 and either gabapentin or pregabalin
AT04010436T ATE380049T1 (en) 1999-10-21 2000-10-17 COMBINATIONS CONTAINING CGMP-PDE5 INHIBITORS.
DE60037347T DE60037347T2 (en) 1999-10-21 2000-10-17 Combinations containing cGMP-PDE5 inhibitor.
ES04010436T ES2295726T3 (en) 1999-10-21 2000-10-17 COMBINATIONS THAT INCLUDE CMP CPDE5 INHIBITORS.
PT04010436T PT1440709E (en) 1999-10-21 2000-10-17 Combinations comprising cgmp pde5 inhibitors.
EP00309129A EP1129706A3 (en) 1999-10-21 2000-10-17 Use of cGMP PDE5 inhibitors for the treatment of neuropathy
DK04010436T DK1440709T3 (en) 1999-10-21 2000-10-17 Combinations comprising cGMP PDE5 inhibitors
EP04010436A EP1440709B1 (en) 1999-10-21 2000-10-17 Combinations comprising cGMP PDE5 inhibitors.
MYPI20004933 MY127989A (en) 1999-10-21 2000-10-19 Treatment of neuropathy
MYPI20024290 MY138266A (en) 1999-10-21 2000-10-19 Treatment of neuropathy
CA002323839A CA2323839C (en) 1999-10-21 2000-10-19 Treatment of neuropathy
CO00080163A CO5271711A1 (en) 1999-10-21 2000-10-20 A COMPOSITION THAT INCLUDES SILDENAFIL OR 3-ETIL-5- [5- (4-ETIL-PIPERAZINA-1-SULFONIL) -2-PROPOXI-PHENYL] -2-PIRIDINH-2-ILMETIL-2.6-DIHYDROPIRAZOL [4,3- D] PIRIMIDIN-7-ONA AND GABAPENTINA OR PREGABALINE FOR THE TREATMENT OF DIABETIC NEUROPATHY
NZ50769000A NZ507690A (en) 1999-10-21 2000-10-20 Treatment of diabetic polyneuropathy using sildenafil (and cGMP-PDE5 inhibitors)
PE2000001133A PE20010754A1 (en) 1999-10-21 2000-10-20 USE OF 3 ', 5'-CYCLIC GUANOSIMMONOPHOSPHATE PHOSPHODIESTERASE INHIBITORS FOR THE TREATMENT OF NEUROPATHY
AU66650/00A AU781550B2 (en) 1999-10-21 2000-10-20 Treatment of neuropathy
HU0004120A HUP0004120A3 (en) 1999-10-21 2000-10-20 Use of cgmp-pde5 inhibitors for the preparation of pharmaceutical compositions treating neuropathy
KR1020000062129A KR20010051181A (en) 1999-10-21 2000-10-21 Treatment of neuropathy
JP2000322510A JP2001122803A (en) 1999-10-21 2000-10-23 Treatment of neuropathy
US10/206,615 US20030162782A1 (en) 1999-10-21 2002-07-26 Treatment of neuropathy
JP2002297617A JP2003119131A (en) 1999-10-21 2002-10-10 Treatment of neuropathy
IL15292502A IL152925A0 (en) 1999-10-21 2002-11-18 Treatment of neuropathy
US10/731,905 US20040122010A1 (en) 1999-10-21 2003-12-10 Treatment of neuropathy
CY20081100193T CY1107285T1 (en) 1999-10-21 2008-02-18 CGMP PDE5 Inhibitors Combined

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9924958.3A GB9924958D0 (en) 1999-10-21 1999-10-21 Treatment of neuropathy

Publications (1)

Publication Number Publication Date
GB9924958D0 true GB9924958D0 (en) 1999-12-22

Family

ID=10863154

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9924958.3A Ceased GB9924958D0 (en) 1999-10-21 1999-10-21 Treatment of neuropathy

Country Status (3)

Country Link
GB (1) GB9924958D0 (en)
MY (2) MY138266A (en)
NZ (1) NZ507690A (en)

Also Published As

Publication number Publication date
NZ507690A (en) 2002-10-25
MY127989A (en) 2007-01-31
MY138266A (en) 2009-05-29

Similar Documents

Publication Publication Date Title
GB2351661B (en) Novel method of treatment
IL145875A0 (en) Novel method of treatment
GB9925136D0 (en) Novel treatment
IL144186A0 (en) Novel treatment
NZ513686A (en) Treatment of trauma
EP1218407A4 (en) Uses of kappa-conotoxin pviia
IL149281A0 (en) Treatment of cancer
GB9930688D0 (en) Novel method of treatment
PL350963A1 (en) Use of arylalkanoylpyridazines
GB9924958D0 (en) Treatment of neuropathy
IL152925A0 (en) Treatment of neuropathy
GB0021520D0 (en) Treatment of neuropathy
AU2002301821A1 (en) Treatment of Neuropathy
GB9930696D0 (en) Novel method of treatment
EP1158991A4 (en) Treatment of asthma
GB9911183D0 (en) Treatment of cancers
GB9926359D0 (en) Treatment of alopecia
GB9917181D0 (en) Methods of treatment
GB9901310D0 (en) Methods of treatment
GB9909650D0 (en) Novel treatment
GB9920788D0 (en) Novel treatment
GB9920787D0 (en) Novel treatment
GB9916655D0 (en) Novel treatment
GB9908993D0 (en) Treatment
GB0122638D0 (en) Novel method of treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)